▶ 調査レポート

世界の熱帯熱マラリア原虫診断市場(~2028年):顕微鏡検査熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断のための薬剤耐性検査、熱帯熱マラリア原虫診断のための抗原検出、その他

• 英文タイトル:Global Plasmodium Falciparum Diagnostics Market Insights, Forecast to 2028

Global Plasmodium Falciparum Diagnostics Market Insights, Forecast to 2028「世界の熱帯熱マラリア原虫診断市場(~2028年):顕微鏡検査熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断のための薬剤耐性検査、熱帯熱マラリア原虫診断のための抗原検出、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-16826
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、熱帯熱マラリア原虫診断のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
熱帯熱マラリア原虫診断のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
熱帯熱マラリア原虫診断の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
熱帯熱マラリア原虫診断のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの熱帯熱マラリア原虫診断の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の熱帯熱マラリア原虫診断の売上および2028年までの予測に焦点を当てています。

熱帯熱マラリア原虫診断のグローバル主要企業には、Abbott Laboratories、Danaher、bioMérieux SA、Siemens AG、Bio-Rad Laboratories, Inc、Leica Microsystems、Nikon Corporation、Sysmex Partec、Olympus Corporation、ZeptoMetrix Corporation、altona Diagnostics GmbH.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

熱帯熱マラリア原虫診断市場は、タイプとアプリケーションによって区分されます。世界の熱帯熱マラリア原虫診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
顕微鏡検査熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断のための薬剤耐性検査、熱帯熱マラリア原虫診断のための抗原検出、その他

【アプリケーション別セグメント】
病院、研究所、診断センター、クリニック、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 熱帯熱マラリア原虫診断製品概要
- タイプ別市場(顕微鏡検査熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断のための薬剤耐性検査、熱帯熱マラリア原虫診断のための抗原検出、その他)
- アプリケーション別市場(病院、研究所、診断センター、クリニック、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の熱帯熱マラリア原虫診断販売量予測2017-2028
- 世界の熱帯熱マラリア原虫診断売上予測2017-2028
- 熱帯熱マラリア原虫診断の地域別販売量
- 熱帯熱マラリア原虫診断の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別熱帯熱マラリア原虫診断販売量
- 主要メーカー別熱帯熱マラリア原虫診断売上
- 主要メーカー別熱帯熱マラリア原虫診断価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(顕微鏡検査熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断のための薬剤耐性検査、熱帯熱マラリア原虫診断のための抗原検出、その他)
- 熱帯熱マラリア原虫診断のタイプ別販売量
- 熱帯熱マラリア原虫診断のタイプ別売上
- 熱帯熱マラリア原虫診断のタイプ別価格
・アプリケーション別市場規模(病院、研究所、診断センター、クリニック、その他)
- 熱帯熱マラリア原虫診断のアプリケーション別販売量
- 熱帯熱マラリア原虫診断のアプリケーション別売上
- 熱帯熱マラリア原虫診断のアプリケーション別価格
・北米市場
- 北米の熱帯熱マラリア原虫診断市場規模(タイプ別、アプリケーション別)
- 主要国別の熱帯熱マラリア原虫診断市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの熱帯熱マラリア原虫診断市場規模(タイプ別、アプリケーション別)
- 主要国別の熱帯熱マラリア原虫診断市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の熱帯熱マラリア原虫診断市場規模(タイプ別、アプリケーション別)
- 主要国別の熱帯熱マラリア原虫診断市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の熱帯熱マラリア原虫診断市場規模(タイプ別、アプリケーション別)
- 主要国別の熱帯熱マラリア原虫診断市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの熱帯熱マラリア原虫診断市場規模(タイプ別、アプリケーション別)
- 主要国別の熱帯熱マラリア原虫診断市場規模(トルコ、サウジアラビア)
・企業情報
Abbott Laboratories、Danaher、bioMérieux SA、Siemens AG、Bio-Rad Laboratories, Inc、Leica Microsystems、Nikon Corporation、Sysmex Partec、Olympus Corporation、ZeptoMetrix Corporation、altona Diagnostics GmbH.
・産業チェーン及び販売チャネル分析
- 熱帯熱マラリア原虫診断の産業チェーン分析
- 熱帯熱マラリア原虫診断の原材料
- 熱帯熱マラリア原虫診断の生産プロセス
- 熱帯熱マラリア原虫診断の販売及びマーケティング
- 熱帯熱マラリア原虫診断の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 熱帯熱マラリア原虫診断の産業動向
- 熱帯熱マラリア原虫診断のマーケットドライバー
- 熱帯熱マラリア原虫診断の課題
- 熱帯熱マラリア原虫診断の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Plasmodium Falciparum Diagnostics estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Plasmodium Falciparum Diagnostics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Plasmodium Falciparum Diagnostics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Plasmodium Falciparum Diagnostics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Plasmodium Falciparum Diagnostics include Abbott Laboratories, Danaher, bioMérieux SA, Siemens AG, Bio-Rad Laboratories, Inc, Leica Microsystems, Nikon Corporation, Sysmex Partec and Olympus Corporation, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Plasmodium Falciparum Diagnostics companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Plasmodium Falciparum Diagnostics market. Further, it explains the major drivers and regional dynamics of the global Plasmodium Falciparum Diagnostics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott Laboratories
Danaher
bioMérieux SA
Siemens AG
Bio-Rad Laboratories, Inc
Leica Microsystems
Nikon Corporation
Sysmex Partec
Olympus Corporation
ZeptoMetrix Corporation
altona Diagnostics GmbH.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Plasmodium Falciparum Diagnostics Segment by Type
Microscopy Tests for Plasmodium Falciparum Diagnostics
Molecular Diagnosis
Serology for Plasmodium Falciparum Diagnostics
Drug Resistance Tests for Plasmodium Falciparum Diagnostics
Antigen Detection for Plasmodium Falciparum Diagnostics
Others
Plasmodium Falciparum Diagnostics Segment by Application
Hospitals
Research Centers
Diagnostic Centers
Clinics
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Plasmodium Falciparum Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Plasmodium Falciparum Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Plasmodium Falciparum Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Plasmodium Falciparum Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasmodium Falciparum Diagnostics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Plasmodium Falciparum Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Plasmodium Falciparum Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Danaher, bioMérieux SA, Siemens AG, Bio-Rad Laboratories, Inc, Leica Microsystems, Nikon Corporation, Sysmex Partec and Olympus Corporation, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Plasmodium Falciparum Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmodium Falciparum Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasmodium Falciparum Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmodium Falciparum Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microscopy Tests for Plasmodium Falciparum Diagnostics
1.2.3 Molecular Diagnosis
1.2.4 Serology for Plasmodium Falciparum Diagnostics
1.2.5 Drug Resistance Tests for Plasmodium Falciparum Diagnostics
1.2.6 Antigen Detection for Plasmodium Falciparum Diagnostics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Plasmodium Falciparum Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Research Centers
1.3.4 Diagnostic Centers
1.3.5 Clinics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasmodium Falciparum Diagnostics Market Perspective (2017-2028)
2.2 Plasmodium Falciparum Diagnostics Growth Trends by Region
2.2.1 Plasmodium Falciparum Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasmodium Falciparum Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Plasmodium Falciparum Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Plasmodium Falciparum Diagnostics Market Dynamics
2.3.1 Plasmodium Falciparum Diagnostics Industry Trends
2.3.2 Plasmodium Falciparum Diagnostics Market Drivers
2.3.3 Plasmodium Falciparum Diagnostics Market Challenges
2.3.4 Plasmodium Falciparum Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmodium Falciparum Diagnostics Players by Revenue
3.1.1 Global Top Plasmodium Falciparum Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Plasmodium Falciparum Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Plasmodium Falciparum Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmodium Falciparum Diagnostics Revenue
3.4 Global Plasmodium Falciparum Diagnostics Market Concentration Ratio
3.4.1 Global Plasmodium Falciparum Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmodium Falciparum Diagnostics Revenue in 2021
3.5 Plasmodium Falciparum Diagnostics Key Players Head office and Area Served
3.6 Key Players Plasmodium Falciparum Diagnostics Product Solution and Service
3.7 Date of Enter into Plasmodium Falciparum Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmodium Falciparum Diagnostics Breakdown Data by Type
4.1 Global Plasmodium Falciparum Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Plasmodium Falciparum Diagnostics Forecasted Market Size by Type (2023-2028)
5 Plasmodium Falciparum Diagnostics Breakdown Data by Application
5.1 Global Plasmodium Falciparum Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Plasmodium Falciparum Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasmodium Falciparum Diagnostics Market Size (2017-2028)
6.2 North America Plasmodium Falciparum Diagnostics Market Size by Type
6.2.1 North America Plasmodium Falciparum Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Plasmodium Falciparum Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Plasmodium Falciparum Diagnostics Market Share by Type (2017-2028)
6.3 North America Plasmodium Falciparum Diagnostics Market Size by Application
6.3.1 North America Plasmodium Falciparum Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Plasmodium Falciparum Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Plasmodium Falciparum Diagnostics Market Share by Application (2017-2028)
6.4 North America Plasmodium Falciparum Diagnostics Market Size by Country
6.4.1 North America Plasmodium Falciparum Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Plasmodium Falciparum Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Plasmodium Falciparum Diagnostics Market Size (2017-2028)
7.2 Europe Plasmodium Falciparum Diagnostics Market Size by Type
7.2.1 Europe Plasmodium Falciparum Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Plasmodium Falciparum Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Plasmodium Falciparum Diagnostics Market Share by Type (2017-2028)
7.3 Europe Plasmodium Falciparum Diagnostics Market Size by Application
7.3.1 Europe Plasmodium Falciparum Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Plasmodium Falciparum Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Plasmodium Falciparum Diagnostics Market Share by Application (2017-2028)
7.4 Europe Plasmodium Falciparum Diagnostics Market Size by Country
7.4.1 Europe Plasmodium Falciparum Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Plasmodium Falciparum Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Type
8.2.1 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Plasmodium Falciparum Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Application
8.3.1 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Plasmodium Falciparum Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Region
8.4.1 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasmodium Falciparum Diagnostics Market Size (2017-2028)
9.2 Latin America Plasmodium Falciparum Diagnostics Market Size by Type
9.2.1 Latin America Plasmodium Falciparum Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Plasmodium Falciparum Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Plasmodium Falciparum Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Plasmodium Falciparum Diagnostics Market Size by Application
9.3.1 Latin America Plasmodium Falciparum Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Plasmodium Falciparum Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Plasmodium Falciparum Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Plasmodium Falciparum Diagnostics Market Size by Country
9.4.1 Latin America Plasmodium Falciparum Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Plasmodium Falciparum Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Type
10.2.1 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Plasmodium Falciparum Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Application
10.3.1 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Plasmodium Falciparum Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Country
10.4.1 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Plasmodium Falciparum Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Plasmodium Falciparum Diagnostics Introduction
11.2.4 Danaher Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.2.5 Danaher Recent Developments
11.3 bioMérieux SA
11.3.1 bioMérieux SA Company Details
11.3.2 bioMérieux SA Business Overview
11.3.3 bioMérieux SA Plasmodium Falciparum Diagnostics Introduction
11.3.4 bioMérieux SA Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.3.5 bioMérieux SA Recent Developments
11.4 Siemens AG
11.4.1 Siemens AG Company Details
11.4.2 Siemens AG Business Overview
11.4.3 Siemens AG Plasmodium Falciparum Diagnostics Introduction
11.4.4 Siemens AG Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.4.5 Siemens AG Recent Developments
11.5 Bio-Rad Laboratories, Inc
11.5.1 Bio-Rad Laboratories, Inc Company Details
11.5.2 Bio-Rad Laboratories, Inc Business Overview
11.5.3 Bio-Rad Laboratories, Inc Plasmodium Falciparum Diagnostics Introduction
11.5.4 Bio-Rad Laboratories, Inc Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.5.5 Bio-Rad Laboratories, Inc Recent Developments
11.6 Leica Microsystems
11.6.1 Leica Microsystems Company Details
11.6.2 Leica Microsystems Business Overview
11.6.3 Leica Microsystems Plasmodium Falciparum Diagnostics Introduction
11.6.4 Leica Microsystems Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.6.5 Leica Microsystems Recent Developments
11.7 Nikon Corporation
11.7.1 Nikon Corporation Company Details
11.7.2 Nikon Corporation Business Overview
11.7.3 Nikon Corporation Plasmodium Falciparum Diagnostics Introduction
11.7.4 Nikon Corporation Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.7.5 Nikon Corporation Recent Developments
11.8 Sysmex Partec
11.8.1 Sysmex Partec Company Details
11.8.2 Sysmex Partec Business Overview
11.8.3 Sysmex Partec Plasmodium Falciparum Diagnostics Introduction
11.8.4 Sysmex Partec Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.8.5 Sysmex Partec Recent Developments
11.9 Olympus Corporation
11.9.1 Olympus Corporation Company Details
11.9.2 Olympus Corporation Business Overview
11.9.3 Olympus Corporation Plasmodium Falciparum Diagnostics Introduction
11.9.4 Olympus Corporation Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.9.5 Olympus Corporation Recent Developments
11.10 ZeptoMetrix Corporation
11.10.1 ZeptoMetrix Corporation Company Details
11.10.2 ZeptoMetrix Corporation Business Overview
11.10.3 ZeptoMetrix Corporation Plasmodium Falciparum Diagnostics Introduction
11.10.4 ZeptoMetrix Corporation Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.10.5 ZeptoMetrix Corporation Recent Developments
11.11 altona Diagnostics GmbH.
11.11.1 altona Diagnostics GmbH. Company Details
11.11.2 altona Diagnostics GmbH. Business Overview
11.11.3 altona Diagnostics GmbH. Plasmodium Falciparum Diagnostics Introduction
11.11.4 altona Diagnostics GmbH. Revenue in Plasmodium Falciparum Diagnostics Business (2017-2022)
11.11.5 altona Diagnostics GmbH. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer